MAPT and Mental deterioration: Overall, further validation studies are needed before adoption of blood p-tau isoforms in the routine diagnostic work-up of people experiencing cognitive decline, in order to validate cut-offs, harmonize inter-laboratory methods, and define the impact of confounding factors.